Now is the time to move beyond misconduct as an academic subject and devote more attention to incorporating better clinical research practices to identify and prevent research fraud.These practices include a partnership of the clinical investigator, institutional review board, and the sponsor. Clinical investigators, corporate managers, and individuals alike would do well to re-examine their own practices for warning signs. The failure to adopt a vigorous approach will lead to new cases of research fraud and ultimately erode away public confidence in the research enterprise.

Was this article helpful?

0 0

Post a comment